Learning Outcome:

After completing this education activity, the learner will be able to discuss the benefit of pharmacogenomics-guided care to improve drug therapy and provide guidance for drug prescribing.

Contact hours available until 12/31/22.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation.

Authors Conflict of Interest Disclosure:

The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.

Katherine K. Sink PhD, APRN-CNS

Appearances